AURA
Aura Biosciences, Inc.Company with tickers: AURA
CIK
1501796
CUSIP
05153U107
Shares Outstanding
103,386,558
13F Activity (30d)
105 filings
105 filers
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-19 | Holles Natalie C. |
Director | Award | 553,844 |
| 2026-05-19 | Holles Natalie C. |
Director | Award | 600,118 |
| 2026-05-19 | Holles Natalie C. |
Director | Award | 2,169,103 |
| 2026-05-07 | Matrix Capital Management Company, LP |
10% Owner | Sell | 6,922,870 |
| 2026-04-30 | Holles Natalie C. |
Director | Other | 0 |
| 2026-04-16 | Kilroy Conor |
See Remarks | Sell | 11,738 |
| 2026-03-02 | Gibney Anthony S |
Director | Award | 128,755 |
| 2026-03-02 | Hopkins Janet Jill |
Chief Medical Officer | Award | 89,056 |
| 2026-03-02 | Kilroy Conor |
See Remarks | Award | 112,661 |
| 2026-03-02 | de los Pinos Elisabet |
Director, See Remarks | Award | 166,000 |
| 2026-03-02 | de los Pinos Elisabet |
Director, See Remarks | Other | 127,763 |
| 2026-03-02 | Elazzouzi Amy |
Senior Vice President, Finance | Award | 44,528 |
| 2026-03-02 | Plavsic Mark |
Chief Technical Officer | Award | 62,339 |
| 2026-03-02 | Elazzouzi Amy |
Senior Vice President, Finance | Award | 80,472 |
| 2026-03-02 | de los Pinos Elisabet |
Director, See Remarks | Award | 249,000 |
| 2026-03-02 | Hopkins Janet Jill |
Chief Medical Officer | Award | 160,944 |
| 2026-03-02 | Gibney Anthony S |
Director | Award | 71,245 |
| 2026-03-02 | Kilroy Conor |
See Remarks | Award | 62,339 |
| 2026-03-02 | Plavsic Mark |
Chief Technical Officer | Award | 112,661 |
| 2026-02-17 | Hopkins Janet Jill |
Chief Medical Officer | Sell | 20,401 |
| 2026-02-17 | Elazzouzi Amy |
Senior Vice President, Finance | Sell | 8,549 |
| 2026-02-17 | de los Pinos Elisabet |
Director, See Remarks | Sell | 47,648 |
| 2026-02-17 | Plavsic Mark |
Chief Technical Officer | Sell | 15,890 |
| 2026-02-17 | Kilroy Conor |
See Remarks | Sell | 12,079 |
| 2026-02-17 | de los Pinos Elisabet |
Director, See Remarks | Other | 127,763 |
| 2026-01-20 | de los Pinos Elisabet |
Director, See Remarks | Other | 127,763 |
| 2026-01-20 | de los Pinos Elisabet |
Director, See Remarks | Sell | 16,928 |
| 2026-01-20 | Elazzouzi Amy |
Senior Vice President, Finance | Sell | 1,581 |
| 2025-11-17 | Hopkins Janet Jill |
Chief Medical Officer | Sell | 17,109 |
| 2025-10-29 | Elazzouzi Amy |
Senior Vice President, Finance | Sell | 896 |
| 2025-10-29 | de los Pinos Elisabet |
Director, See Remarks | Other | 127,763 |
| 2025-10-29 | de los Pinos Elisabet |
Director, See Remarks | Sell | 9,049 |
| 2025-10-16 | Plavsic Mark |
Chief Technical Officer | Sell | 12,169 |
| 2025-08-18 | Elazzouzi Amy |
Senior Vice President, Finance | Convert | 2,554 |
| 2025-08-18 | Elazzouzi Amy |
Senior Vice President, Finance | Convert | 1,094 |
| 2025-08-18 | Elazzouzi Amy |
Senior Vice President, Finance | Convert | 4,744 |
| 2025-08-18 | Elazzouzi Amy |
Senior Vice President, Finance | Convert | 547 |
| 2025-08-18 | Elazzouzi Amy |
Senior Vice President, Finance | Convert | 1,094 |
| 2025-08-18 | Elazzouzi Amy |
Senior Vice President, Finance | Convert | 2,319 |
| 2025-08-18 | Elazzouzi Amy |
Senior Vice President, Finance | Convert | 2,319 |
| 2025-08-18 | Elazzouzi Amy |
Senior Vice President, Finance | Convert | 1,094 |
| 2025-08-18 | Elazzouzi Amy |
Senior Vice President, Finance | Convert | 4,744 |
| 2025-08-18 | Elazzouzi Amy |
Senior Vice President, Finance | Convert | 547 |
| 2025-08-18 | Elazzouzi Amy |
Senior Vice President, Finance | Convert | 547 |
| 2025-08-18 | Elazzouzi Amy |
Senior Vice President, Finance | Convert | 547 |
| 2025-08-18 | Elazzouzi Amy |
Senior Vice President, Finance | Sell | 7,722 |
| 2025-08-18 | Elazzouzi Amy |
Senior Vice President, Finance | Convert | 2,554 |
| 2025-08-18 | Elazzouzi Amy |
Senior Vice President, Finance | Convert | 1,094 |
| 2025-06-17 | Mattessich Antony C. |
Director, President and CEO | Award | 17,000 |
| 2025-06-17 | Srivastava Sapna |
Director | Award | 13,000 |
Showing 1–50 of 293 transactions